On December 30th, 2017, Resolution of the Cabinet of Ministers of Ukraine No. 1081 dated December 13 th, 2017 came into force and approved the new edition of the National List.
The updated National List includes 427 INNs.
The project has been developed in accordance with the recently adopted amendments to the Regulations on the National List of Essential Medicines and the Regulations on the Expert Committee on the Selection and Use of Essential Medicines, which has been mentioned here.
Thus, the Expert Committee on the Selection and Use of Essential Medicines conducted an analysis of clinical efficacy and safety of medicinal products confirmed by evidence-based medicine (without pharmacoeconomic analysis) recommended for inclusion in the National List of Essential Medicines following the "fast-track" procedure. As a result of such work, it is proposed to supplement the National List with the following drugs:
The National List in the revised edition will become the basis for public procurement in 2018.
Subsequently, the National List will be supplemented by new positions based on applications of individuals and legal entities, in particular, holders of registration certificates, on the results of their consideration by the Expert Committee. Applications are accepted throughout the calendar year.
Previously, these issues were actively discussed during the Conference "Healthcare And Pharmaceuticals - 2018. Anticipations And Expectations", held on December 13-14 in Kyiv.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.